Novel Iron-Based Phosphate Binder Effective, Well-ToleratedRenal and Urology NewsIn the trial, which compared PA21 with sevelamer hydrochloride, 152 HD patients received a fixed-dose regimen of either PA21 (1.
Japan Tobacco, Torii report positive top-line results from Phase III Zerenex study - Pharmaceutical Business Review
Japan Tobacco, Torii report positive top-line results from Phase III Zerenex studyPharmaceutical Business ReviewThe primary endpoint of efficacy has met non-inferiority to sevelamer hydrochloride in the top-line results, which evaluated the change of serum phosphorus from baseline.
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files ... - Proactive Investors USA & Canada